Location History:
- Hillsborough, NZ (1997 - 1999)
- Auckland, NZ (1984 - 2009)
Company Filing History:
Years Active: 1984-2009
Title: **Innovator Bruce Charles Baguley: Pioneering Cancer Research**
Introduction
Bruce Charles Baguley is an accomplished inventor based in Auckland, New Zealand. With a remarkable portfolio of 15 patents, he has made significant contributions to the field of cancer treatment. His innovative approaches leverage advanced biochemical compounds, reflecting his dedication to transforming cancer therapy.
Latest Patents
Among Bruce's latest inventions, two notable patents stand out. The first patent, titled "Anti-cancer composition comprising DMXAA or related compound," focuses on the use of compounds such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) for cancer treatment. This invention emphasizes gastrointestinal delivery, ideally through oral administration, and highlights the strategy of administering the compound in two or more doses to enhance therapeutic effectiveness.
The second patent, "Cancer treatment by combination therapy," offers methods and compositions for effectively treating cancer. This innovation involves administering, either sequentially or simultaneously, a compound from the xanthenone acetic acid group alongside a compound that modulates TNF production. The resulting compositions include these dual-action ingredients mixed with acceptable pharmaceutical carriers, showcasing Bruce's commitment to advancing cancer therapies.
Career Highlights
Bruce Charles Baguley has a prestigious career marked by his work with reputable organizations, including the Development Finance Corporation of New Zealand and Cancer Research Technology Limited. His experience in these companies has propelled him to the forefront of cancer research and innovation.
Collaborations
Throughout his career, Baguley has collaborated with esteemed colleagues such as William Alexander Denny and Graham John Atwell. Together, they have shared insights and expertise, contributing to the advancement of cancer treatment methodologies.
Conclusion
In summary, Bruce Charles Baguley exemplifies the spirit of innovation in medical science. His dedication to researching and developing cancer treatment options has positioned him as a prominent figure in the field. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for breakthroughs that have the potential to improve countless lives.